EDAP TMS Past Earnings Performance
Past criteria checks 0/6
EDAP TMS's earnings have been declining at an average annual rate of -68.3%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 9.4% per year.
Key information
-68.3%
Earnings growth rate
-66.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 9.4% |
| Return on equity | -51.9% |
| Net Margin | -34.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Potential Upside For EDAP TMS S.A. (NASDAQ:EDAP) Not Without Risk
Dec 25
Is EDAP TMS (NASDAQ:EDAP) Using Debt In A Risky Way?
Oct 24Slammed 35% EDAP TMS S.A. (NASDAQ:EDAP) Screens Well Here But There Might Be A Catch
Sep 07Fewer Investors Than Expected Jumping On EDAP TMS S.A. (NASDAQ:EDAP)
Jul 24There's Reason For Concern Over EDAP TMS S.A.'s (NASDAQ:EDAP) Massive 28% Price Jump
Mar 22Does EDAP TMS (NASDAQ:EDAP) Have A Healthy Balance Sheet?
Mar 03It's A Story Of Risk Vs Reward With EDAP TMS S.A. (NASDAQ:EDAP)
Jan 19Investors Still Waiting For A Pull Back In EDAP TMS S.A. (NASDAQ:EDAP)
Aug 11Is There An Opportunity With EDAP TMS S.A.'s (NASDAQ:EDAP) 20% Undervaluation?
Dec 19EDAP TMS' (NASDAQ:EDAP) Solid Profits Have Weak Fundamentals
Nov 23EDAP TMS stock falls 7% aftermarket on proposed ADS offering
Sep 22EDAP TMS S.A. GAAP EPS of $0.06 beats by $0.09, revenue of $14.97M beats by $1.35M
Aug 24EDAP's Focal One Revenue Is Set To Accelerate
Aug 08Is EDAP TMS (NASDAQ:EDAP) Weighed On By Its Debt Load?
Jul 19Acceleration At EDAP
Jan 11EDAP TMS (NASDAQ:EDAP) Could Easily Take On More Debt
Jan 06The Consensus EPS Estimates For EDAP TMS S.A. (NASDAQ:EDAP) Just Fell A Lot
Nov 25EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real
Sep 07EDAP's subsidiary names medTech industry veteran Ryan Rhodes as CEO
Jun 15EDAP TMS S.A. (NASDAQ:EDAP) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
Apr 02Analysts Are Betting On EDAP TMS S.A. (NASDAQ:EDAP) With A Big Upgrade This Week
Jan 24
Treatment with EDAP's HIFU ultrasound benefits in prostate cancer patients, study shows
Jan 14New reimbursement rules for HIFU technology to favor EDAP TMS
Dec 09Revenue & Expenses Breakdown
How EDAP TMS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 63 | -22 | 35 | 8 |
| 30 Jun 24 | 62 | -20 | 34 | 8 |
| 31 Mar 24 | 61 | -18 | 32 | 8 |
| 31 Dec 23 | 60 | -21 | 34 | 7 |
| 30 Sep 23 | 57 | -21 | 35 | 6 |
| 30 Jun 23 | 57 | -17 | 33 | 6 |
| 31 Mar 23 | 57 | -11 | 30 | 5 |
| 31 Dec 22 | 55 | -3 | 24 | 5 |
| 30 Sep 22 | 53 | 4 | 21 | 4 |
| 30 Jun 22 | 51 | 3 | 20 | 4 |
| 31 Mar 22 | 47 | 0 | 18 | 4 |
| 31 Dec 21 | 44 | 1 | 17 | 3 |
| 30 Sep 21 | 45 | 0 | 15 | 4 |
| 30 Jun 21 | 45 | 0 | 14 | 4 |
| 31 Mar 21 | 44 | 0 | 13 | 4 |
| 31 Dec 20 | 42 | -2 | 14 | 4 |
| 30 Sep 20 | 38 | -3 | 14 | 4 |
| 30 Jun 20 | 39 | -2 | 14 | 4 |
| 31 Mar 20 | 42 | 0 | 15 | 4 |
| 31 Dec 19 | 45 | 2 | 15 | 4 |
| 30 Sep 19 | 46 | 4 | 15 | 4 |
| 30 Jun 19 | 44 | 2 | 15 | 4 |
| 31 Mar 19 | 40 | 0 | 14 | 4 |
| 31 Dec 18 | 39 | 0 | 14 | 4 |
| 30 Sep 18 | 36 | -1 | 13 | 4 |
| 30 Jun 18 | 35 | -1 | 13 | 4 |
| 31 Mar 18 | 36 | -2 | 13 | 4 |
| 31 Dec 17 | 36 | -1 | 13 | 4 |
| 30 Sep 17 | 36 | -2 | 13 | 4 |
| 30 Jun 17 | 37 | 0 | 13 | 4 |
| 31 Mar 17 | 36 | 4 | 12 | 4 |
| 31 Dec 16 | 36 | 4 | 12 | 4 |
| 30 Sep 16 | 37 | 10 | 12 | 3 |
| 30 Jun 16 | 35 | 4 | 11 | 3 |
| 31 Mar 16 | 35 | 2 | 11 | 3 |
| 31 Dec 15 | 32 | -2 | 11 | 3 |
| 30 Sep 15 | 27 | -9 | 10 | 3 |
| 30 Jun 15 | 27 | 2 | 10 | 3 |
| 31 Mar 15 | 25 | -4 | 10 | 3 |
| 31 Dec 14 | 26 | -1 | 10 | 3 |
| 30 Sep 14 | 28 | 2 | 10 | 3 |
| 30 Jun 14 | 27 | -5 | 9 | 3 |
| 31 Mar 14 | 26 | 0 | 9 | 2 |
Quality Earnings: EDAP is currently unprofitable.
Growing Profit Margin: EDAP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EDAP is unprofitable, and losses have increased over the past 5 years at a rate of 68.3% per year.
Accelerating Growth: Unable to compare EDAP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EDAP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).
Return on Equity
High ROE: EDAP has a negative Return on Equity (-51.87%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/27 13:45 |
| End of Day Share Price | 2025/01/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EDAP TMS S.A. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew D'Silva | B. Riley Securities, Inc. |
| null null | CG Capital |
| Swayampakula Ramakanth | H.C. Wainwright & Co. |